EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TRIM58 Interacts with ZEB1 to Suppress NSCLC Tumor Malignancy by Promoting ZEB1 Protein Degradation via UPP

Rongxin Shang iD, Jiakuan Chen iD, Yang Gao iD, Jijun Chen iD, Guoliang Han iD

Disease Markers · 2023

DOI: 10.1155/2023/5899662 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Disease Markers, 2023. Verfasst von Rongxin Shang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The Second Affiliated Hospital of Air Force Medical University, Xi'an, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Zinc Finger E-box-Binding Homeobox 1, Tripartite Motif Proteins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Second Affiliated Hospital of Air Force Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Currently, how to successfully control refractory and metastatic diseases remains a fundamental goal for clinicians to improve therapeutic effects for patients with non-small cell lung cancer (NSCLC). Several studies have discovered that TRIM58, a member of tripartite motif protein family, shows antitumor effect in multiple types of cancer. In this study, we aimed to further clarify the molecular regulatory network of TRIM58 and corresponding targets for NSCLC patients.

Methods

TRIM58 expression in clinical tumor tissue samples and cancer cell lines was examined. Functional experiments including cellular invasion, cell metastasis, chemoresistance assay, and ubiquitination evaluation experiments were conducted to investigate the interaction between TRIM58 and ZEB1, which is a prime element of transcription factor network that controls epithelial-to-mesenchymal transition.

Results

TRIM58 expression was characteristically decreased in NSCLC tumor tissues and cancer cell lines. Functional experiments demonstrated that TRIM58 suppression enhanced malignant biological behaviors including cellular survivability, migration, and invasion, as well as stem-like cellular phenotype of tumor cells. TRIM58 silencing also significantly enhanced the chemoresistance of NSCLC cells to chemoagents. TRIM58-ZEB1 interaction accelerated degradation of ZEB1 protein, thus further leading to the augment of tumor behaviors. Further detailed molecular experiments revealed that the interaction between TRIM58 and ZEB1 was mediated via ubiquitin-proteasome pathway (UPP).

Conclusion

TRIM58 suppressed NSCLC through interacting with ZEB1 and promoting ZEB1 protein degradation via UPP. The present research sheds light on the interaction between TRIM58 and ZEB1, and TRIM58/ZEB1 axis might be the potential therapeutic targets of NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsZinc Finger E-box-Binding Homeobox 1Tripartite Motif ProteinsHumansCell Line, TumorEpithelial-Mesenchymal TransitionProteolysisUbiquitinationProteasome Endopeptidase ComplexUbiquitin

Substanzen

ZEB1 protein, humanZinc Finger E-box-Binding Homeobox 1TRIM58 protein, humanTripartite Motif ProteinsProteasome Endopeptidase ComplexUbiquitin

Autor:innen und Institutionen

  • Department of Thoracic Surgery, The Second Affiliated Hospital of Air Force Medical University, Xi'an, China.
  • Department of Thoracic Surgery, The First Affiliated Hospital of Air Force Medical University, Xi'an, China.

ORCID-Profile: Rongxin Shang, Jiakuan Chen, Yang Gao, Jijun Chen, Guoliang Han

Förderung

  • Second Affiliated Hospital of Air Force Medical University

Zitieren

APA

Shang, R., Chen, J., Gao, Y., Chen, J., & Han, G. (2023). TRIM58 Interacts with ZEB1 to Suppress NSCLC Tumor Malignancy by Promoting ZEB1 Protein Degradation via UPP. Disease Markers. https://doi.org/10.1155/2023/5899662

Vancouver

Shang R, Chen J, Gao Y, Chen J, Han G. TRIM58 Interacts with ZEB1 to Suppress NSCLC Tumor Malignancy by Promoting ZEB1 Protein Degradation via UPP. Disease Markers. 2023. doi:10.1155/2023/5899662

BibTeX
@article{Shang2023,
  author = {Shang, Rongxin and Chen, Jiakuan and Gao, Yang and Chen, Jijun and Han, Guoliang},
  title = {TRIM58 Interacts with ZEB1 to Suppress NSCLC Tumor Malignancy by Promoting ZEB1 Protein Degradation via UPP},
  journal = {Disease Markers},
  year = {2023},
  doi = {10.1155/2023/5899662}
}
Kostenlos starten →